Teva Pharmaceutical Industries gave a tough fight to protect the patent of the best- sold drug in the market. Teva Pharmaceutical Industries has lost the challenge, as they are not permitted to market the generic version of the Viagra.
As Pfizer Pharma has won the legal battle, and can retain the patent rights of the most blockbuster drug, that cures male impotent, called as Viagra. The major drug used for the preparation of Viagra is Slidenafil Citrate. Teva Pharmaceutical Industries will not be allowed to market the generic version of this medicine till October, 2019, by order.
As Pfizer Pharma, continues to carry on with the exclusive right into producing and marketing Viagra. The management of Pfizer Pharma is extremely content about the fact that the court has understood the necessity and the effectiveness of this drug which is used to treat erectile dysfunction (ED) or male impotent. Pfizer Pharma, also says that court has not only protected their intellectual property rights; but has also protected their patent rights from getting violated in the market.
Teva Pharmaceutical Industries builds a victorious generics industry, standing to test the patents exclusively for the owned drugs. Teva is now finding itself to the other side where they have secured its own owned products. Teva Pharmaceutical Industries has declared that even they are satisfied with the court’s result and are waiting to begin an experiment on September 7, 2011’.
As Pfizer Pharma has won the legal battle, and can retain the patent rights of the most blockbuster drug, that cures male impotent, called as Viagra. The major drug used for the preparation of Viagra is Slidenafil Citrate. Teva Pharmaceutical Industries will not be allowed to market the generic version of this medicine till October, 2019, by order.
As Pfizer Pharma, continues to carry on with the exclusive right into producing and marketing Viagra. The management of Pfizer Pharma is extremely content about the fact that the court has understood the necessity and the effectiveness of this drug which is used to treat erectile dysfunction (ED) or male impotent. Pfizer Pharma, also says that court has not only protected their intellectual property rights; but has also protected their patent rights from getting violated in the market.
Teva Pharmaceutical Industries builds a victorious generics industry, standing to test the patents exclusively for the owned drugs. Teva is now finding itself to the other side where they have secured its own owned products. Teva Pharmaceutical Industries has declared that even they are satisfied with the court’s result and are waiting to begin an experiment on September 7, 2011’.
No comments:
Post a Comment